We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Alliance to Develop Molecular Imaging Techniques

By HospiMedica staff writers
Posted on 17 Sep 2002
A collaboration to undertake development of molecular imaging techniques for use in ultrasound, magnetic resonance, and nuclear medicine has been announced by Philips Medical Systems (Best, The Netherlands) and Kereos (St.Louis, MO, USA).

The collaboration will focus on image-based characterization of the molecular causes of diseases and will combine Kereos' targeted nanoparticle technology with Philips' engineering, software development, and equipment support. The goal is to facilitate development of molecular imaging agents for specific and sensitive detection of tumors and vulnerable plaque in arteries, a major cause of heart disease. The leader of the project is Dr. Samuel A. Wickline, M.D., professor of medicine, biomedical engineering, and physics at Washington University School of Medicine in St. Louis (MO, USA).

"Our team is very excited about this agreement,” said Dr. Wickline. "We are certain that it will quickly lead to major breakthroughs in advancing contrast agent and scanner technology for molecular imaging and targeted therapeutics.”





Related Links:
Philips Medical Systems
Kereos
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
New
Head Rest
Medifa 61114_3

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more